Developer docs
API playgroundTry for free, no card

Search company profiles

Karolinska Universitetssjukhuset

Full company profile

uuid000h59o

Namestring
Karolinska Universitetssjukhuset
Legal namestring
Karolinska Universitetssjukhuset
Websiteurl
karolinska.se
Company typeenum
Public
Founded yearint
1940
Descriptiontext

Karolinska Universitetssjukhuset is a public university hospital owned and operated by Region Stockholm, operating two main campuses in Huddinge (Hälsovägen 13) and Solna (Eugeniavägen 3) plus additional sites including the Astrid Lindgrens barnsjukhus pediatric hospital, Barnahus Stockholm, and the regional Stockholm Medical Biobank network spanning four Stockholm hospitals and Gotland. The hospital provides specialized and nationally designated highly specialized care (nationell högspecialiserad vård) across multiple rare conditions, runs more than 1,000 concurrent clinical trials, and participates in 20 European Reference Networks. Its core technology stack includes the TakeCare electronic journal system, the Alltid Öppet digital patient platform and 1177 e-tjänster for patient access, Karolinska Hälsodata for health-data extraction, a Translational Research Center (TRACK), and the Precisionsmedicinskt centrum Karolinska (PMCK) for genomic and personalized medicine. Recent AI and XR initiatives include a breast-cancer detection program built jointly with KTH and extended-reality tools deployed in pediatric care.

Revenue is structurally non-commercial: the hospital is funded principally through the Region Stockholm public healthcare budget, with secondary income from regulated patient fees, national referral funding for designated highly specialized services, research grants (including EIT Health, Vinnova, EU), and biobank and clinical-trial services sold to pharmaceutical, biotech, and academic customers. Go-to-market is direct-to-patient within Sweden's public system — patients arrive via primary-care referrals, the national 1177 healthcare advice line, or emergency (112/SOS Alarm). Customer segments are therefore four: Swedish patients requiring specialized care, referring primary-care physicians and other hospitals, medical researchers (anchored by the partnership with Karolinska Institutet), and industry partners in pharma, medtech, and biotech seeking research and clinical-trial collaboration.

Operationally the hospital is led by Sjukhusdirektör Christophe Pedroletti and integrates with Karolinska Institutet through joint facilities including BioClinicum, TRACK, PMCK, and a consolidated Stockholm biobank infrastructure. Recent strategic emphasis is on AI leadership (new Chief AI Officer Joel Preger), innovation support capacity (new Head of Innovation Support Andreas Lundquist), and a regional life-science strategy co-developed with Region Stockholm and Region Uppsala.

Short descriptiontext

Karolinska Universitetssjukhuset is a public university hospital owned by Region Stockholm, operating two main campuses (Huddinge, Solna) plus pediatric and biobank sites, delivering specialized and nationally designated highly specialized care, clinical research (over 1,000 trials), and digital health services to Swedish patients and industry partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersHuddinge, Sweden
HQ citystring
Huddinge
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
university hospital services, specialized healthcare, clinical research, pediatric hospital care, health data services
Industry2 codes
1Oncology & Cancer Specialty Hospitals
CodeHLAFAHACPrimaryYes
2Hospital-Integrated Cancer Centers (Acute Oncology Programs)
CodeHLAFAAAMPrimaryNo
NAICS code2 codes
  • General Medical and Surgical Hospitals62211
  • Specialty (except Psychiatric and Substance Abuse) Hospitals622310
SIC code2 codes
  • Services-Hospitals8060
  • Services-General Medical & Surgical Hospitals, Nec8062
Product category
University Hospital Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Public Healthcare Funding
TypeSubscription Recurring
Description

As a regional university hospital owned by Region Stockholm, the hospital receives government funding for healthcare services provided to the population.

karolinska.se
2Patient Fees
TypeTransaction Fee
Description

Standard patient fees regulated by Swedish healthcare system. Patients pay visit fees according to regional healthcare fee schedules.

karolinska.se
3Research Grants and Funding
TypeLicensing Royalties
Description

The hospital receives research funding through collaborations with Karolinska Institutet, international research grants (EIT Health, Vinnova, EU), and regional research funds for clinical trials and biomedical research.

karolinska.se
4Biobank Services
TypeProfessional Services
Description

Stockholms medicinska biobank provides services to researchers, pharmaceutical companies, and biotech firms, generating revenue through sample storage and access fees.

karolinska.se
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Infrastructure
Pricing details1 tier
1Standard patient visit fees
ModelUnit PricingBilling cadencePer visit
Notes

Patient visit fees apply for consultations and treatments. Patients who miss appointments or don't cancel in time (at least 24 hours before) pay the visit fee even with free card or under 18 years. Frikort (free card) exempts patients from additional fees after reaching the annual threshold.

karolinska.se
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 record
1Astrid Lindgrens barnsjukhus
Description

A specialized pediatric hospital within Karolinska Universitetssjukhuset, providing specialized and highly specialized care for children from across Sweden. Handles approximately 180,000 patient visits per year including 55,000 acute visits.

karolinska.se
Core offering1 text field

Karolinska Universitetssjukhuset is a public university hospital providing specialized and highly specialized healthcare to patients across Stockholm and Sweden. It operates two main campuses (Huddinge and Solna), runs over 1,000 clinical studies, and integrates clinical care with research, education and innovation in collaboration with Karolinska Institutet. Offerings include emergency and inpatient care, outpatient clinics, pediatric services (Astrid Lindgrens barnsjukhus), national highly specialized care assignments, digital patient services, a regional biobank, and clinical trial support.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 4th best hospital in the world, best in Europe (2026 Newsweek ranking)
+4 more records
Product overview1 text field

Karolinska Universitetssjukhuset operates as a university hospital with a portfolio of specialized healthcare services and digital platforms. Key offerings include Astrid Lindgrens barnsjukhus (children's hospital), digital patient services (Alltid Öppet, 1177 e-tjänster), Karolinska Hälsodata for health data extraction, Precisionsmedicinskt centrum Karolinska (PMCK) for precision medicine, Translational Research Center TRACK for clinical research, Karolinska Trial Alliance (KTA) for clinical trial services, and Stockholms medicinska biobank for sample storage. The hospital also offers Stepstones transition program for adolescent patients moving to adult care.

Product and service10 records
1Astrid Lindgrens barnsjukhus (Astrid Lindgren Children's Hospital)
CategorySpecialized pediatric hospital services
2Alltid Öppet
CategoryDigital patient service
31177 e-tjänster
CategoryDigital patient service
4Karolinska Hälsodata
CategoryHealth data service
5Precisionsmedicinskt centrum Karolinska (PMCK)
CategorySpecialized medicine center
6Translational Research Center Karolinska University Hospital (TRACK)
CategoryTranslational research infrastructure
7Karolinska Trial Alliance (KTA)
CategoryClinical trials training and support
8Stockholms medicinska biobank (Stockholm Medical Biobank)
CategoryBiobank services
9Nationell högspecialiserad vård (National Highly Specialized Care)
CategoryHighly specialized healthcare services
10Barnahus Stockholm
CategoryChild protection and forensic services
Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-18
Description

Collaboration to strengthen precision medicine development in Sweden and improve conditions for patients. Partnership focuses on research collaboration and implementation of precision medicine approaches.

2Okhmatdyt Children's Hospital (Ukraine)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2025-12-09
Description

Fellowship program where Ukrainian healthcare professionals from Okhmatdyt in Kiev visit Astrid Lindgrens barnsjukhus for training and exchange. Ongoing collaboration supporting Ukraine's largest children's hospital.

karolinska.se
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2024-12-10
Description

Multi-agency collaboration at Barnahus Stockholm (child protection center) bringing together police, prosecutor, social services, and child psychiatry under one roof. Largest Barnahus in Europe.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-06-28
Description

Cooperation agreement signed between Region Stockholm and Île-de-France covering innovation, digital transformation, and sustainable future. Includes collaboration on AR in spine surgery and biotech.

Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-06-28
Description

Joint venture developing silicon-based computed tomography technology with potential for significant patient benefits if transitioned to clinical use. Regional partnership between academia, industry, and clinical care.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-06-28
Description

20-year international collaboration on pediatric hospital care with exchange visits and experience sharing. Regular study visits between the institutions.

Strategic tierMajorTypeTechnology or IntegrationAnnounced on2022-06-07
Description

Collaboration on AI development for breast cancer detection. AI program developed jointly with KTH to help radiologists identify patients who would benefit most from supplementary MRI examinations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-29
Description

Strategic partnership between Karolinska Universitetssjukhuset and Karolinska Institutet for medical research, education, and innovation. Includes joint biobank collaboration, Precisionsmedicinskt centrum Karolinska (PMCK), and Translational Research Center (TRACK). The partnership integrates healthcare, research, and education with shared facilities including BioClinicum.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-29
Description

Karolinska Universitetssjukhuset operates as Region Stockholm's university hospital, providing specialized and highly specialized healthcare. Partnership includes Life Science strategy development and Stockholm Medical Biobank operations.

10Stockholms medicinska biobank (SMB)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-29
Description

Regional biobank operated by Karolinska for Region Stockholm serving patients at Karolinska, Södersjukhuset, Danderyds sjukhus, and Gotland. Over 45 million samples collected.

karolinska.se
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-26
Description

National force for precision medicine implementation enabling all Swedish patients access to genetic sequencing for diagnosis and personalized treatment. Led by Richard Rosenquist Brandell from Karolinska.

12Translational Research Center Karolinska (TRACK)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-26
Description

Research hotel in Huddinge facilitating collaboration between preclinical and clinical researchers. Includes Karolinska Center for Cell Therapy, Mutation Analysis Unit, and Preclinical Imaging Unit (PIF).

karolinska.se
Strategic tierMajorTypeStrategic or Co-development PartnerAnnounced on2022-04-01
Description

International research collaboration for precision prevention in rheumatology receiving 23 million SEK grant. Partners include KI, Elsa Science, ThermoFisher Scientific, Friedrich Alexander University (Germany), and Leiden University Medical Center (Netherlands).

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-09-01
Description

Clinical trial support organization providing GCP training, clinical trial methodology courses, and research nurse education. Offers courses in Good Clinical Practice and clinical trial management.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sweden's second-largest university hospital in Gothenburg operated by Västra Götalandsregionen. Direct Nordic peer offering the same specialized and nationell högspecialiserad vård designations, similar clinical research scale, and competing for talent, research funding, and complex referrals from western Sweden.

TypeDirect peer
Description

University hospital in Lund/Malmö operated by Region Skåne, affiliated with Lund University. Comparable as a Swedish academic medical center providing tertiary and quaternary care, conducting similar clinical research, and competing for nationell högspecialiserad vård mandates.

TypeDirect peer
Description

University hospital in Region Uppsala affiliated with Uppsala University. Direct peer providing specialized care and clinical research; recently joined Karolinska's AstraZeneca precision medicine collaboration, underscoring strategic overlap rather than pure competition.

TypeDirect peer
Description

Norway's largest university hospital and Karolinska's 20-year pediatric collaboration partner. Comparable Nordic academic medical center providing national highly specialized care and competing for European Reference Network leadership and cross-border clinical research visibility.

TypeBroad incumbent
Description

Denmark's flagship university hospital providing highly specialized national care. Comparable Nordic academic medical center, often larger in specific specialty areas, and competing with Karolinska for European Reference Network status and global patient referrals.

TypeBroad incumbent
Description

Finland's largest hospital district and academic medical center. Comparable as a Nordic specialty hospital provider with active research portfolio and cross-border partnerships, serving as a peer for both patient referrals and clinical research collaborations.

TypeBroad incumbent
Description

One of Europe's largest university hospitals, jointly operated by Freie Universität Berlin and Humboldt-Universität. Comparable to Karolinska as a major European academic medical center with extensive research portfolio, large biobank infrastructure, and membership in multiple European Reference Networks.

TypeOthers
Description

Sweden's premier medical university and Karolinska's primary academic partner. While a research and education institution rather than a healthcare provider, it is the closest comparable organization due to shared brand, joint biobank infrastructure (TRACK, PMCK), and overlapping talent pipeline that drives Karolinska's research output.

TypeRegional player
Description

Switzerland's largest university hospital providing highly specialized care and clinical research. Comparable European academic medical center that does not directly compete in the Nordics but competes for European Reference Network leadership and global reputation rankings.

TypeRegional player
Description

University medical center in Rotterdam combining hospital care, research, and education. Comparable European academic medical center with strong AI and digital health capabilities, competing with Karolinska for European Reference Network participation and clinical research visibility.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses3 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability5 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles12 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Karolinska Universitetssjukhuset

University Hospital Serviceskarolinska.se

Karolinska Universitetssjukhuset is a public university hospital owned by Region Stockholm, operating two main campuses (Huddinge, Solna) plus pediatric and biobank sites, delivering specialized and nationally designated highly specialized care, clinical research (over 1,000 trials), and digital health services to Swedish patients and industry partners.

What Karolinska Universitetssjukhuset does

Karolinska Universitetssjukhuset is a public university hospital owned and operated by Region Stockholm, operating two main campuses in Huddinge (Hälsovägen 13) and Solna (Eugeniavägen 3) plus additional sites including the Astrid Lindgrens barnsjukhus pediatric hospital, Barnahus Stockholm, and the regional Stockholm Medical Biobank network spanning four Stockholm hospitals and Gotland. The hospital provides specialized and nationally designated highly specialized care (nationell högspecialiserad vård) across multiple rare conditions, runs more than 1,000 concurrent clinical trials, and participates in 20 European Reference Networks. Its core technology stack includes the TakeCare electronic journal system, the Alltid Öppet digital patient platform and 1177 e-tjänster for patient access, Karolinska Hälsodata for health-data extraction, a Translational Research Center (TRACK), and the Precisionsmedicinskt centrum Karolinska (PMCK) for genomic and personalized medicine. Recent AI and XR initiatives include a breast-cancer detection program built jointly with KTH and extended-reality tools deployed in pediatric care.

Revenue is structurally non-commercial: the hospital is funded principally through the Region Stockholm public healthcare budget, with secondary income from regulated patient fees, national referral funding for designated highly specialized services, research grants (including EIT Health, Vinnova, EU), and biobank and clinical-trial services sold to pharmaceutical, biotech, and academic customers. Go-to-market is direct-to-patient within Sweden's public system — patients arrive via primary-care referrals, the national 1177 healthcare advice line, or emergency (112/SOS Alarm). Customer segments are therefore four: Swedish patients requiring specialized care, referring primary-care physicians and other hospitals, medical researchers (anchored by the partnership with Karolinska Institutet), and industry partners in pharma, medtech, and biotech seeking research and clinical-trial collaboration.

Operationally the hospital is led by Sjukhusdirektör Christophe Pedroletti and integrates with Karolinska Institutet through joint facilities including BioClinicum, TRACK, PMCK, and a consolidated Stockholm biobank infrastructure. Recent strategic emphasis is on AI leadership (new Chief AI Officer Joel Preger), innovation support capacity (new Head of Innovation Support Andreas Lundquist), and a regional life-science strategy co-developed with Region Stockholm and Region Uppsala.

Karolinska Universitetssjukhuset firmographics

Firmographics
Name
Karolinska Universitetssjukhuset
Legal name
Karolinska Universitetssjukhuset
Website
https://karolinska.se
Company type
Public
Founded year
1940
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
Karolinska Universitetssjukhuset is a public university hospital owned by Region Stockholm, operating two main campuses (Huddinge, Solna) plus pediatric and biobank sites, delivering specialized and nationally designated highly specialized care, clinical research (over 1,000 trials), and digital health services to Swedish patients and industry partners.
Ownership category
akta.pro rank

Karolinska Universitetssjukhuset industry classification

Industry
Product category
University Hospital Services
NAICS
General Medical and Surgical Hospitals (62211), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310)
SIC
Services-Hospitals (8060), Services-General Medical & Surgical Hospitals, Nec (8062)
akta.pro primary industry
Oncology & Cancer Specialty Hospitals (HLAFAHAC)
akta.pro secondary industry
Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)

Keywords

  • University hospital services
  • Specialized healthcare
  • Clinical research
  • Pediatric hospital care
  • Health data services

Where Karolinska Universitetssjukhuset is headquartered

Location

Headquarters

HQ city
Huddinge
HQ country
Sweden
HQ region
Europe

Offices4 records

Markets served

Karolinska Universitetssjukhuset business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

  1. Public Healthcare Funding: As a regional university hospital owned by Region Stockholm, the hospital receives government funding for healthcare services provided to the population.
  2. Patient Fees: Standard patient fees regulated by Swedish healthcare system. Patients pay visit fees according to regional healthcare fee schedules.
  3. Research Grants and Funding: The hospital receives research funding through collaborations with Karolinska Institutet, international research grants (EIT Health, Vinnova, EU), and regional research funds for clinical trials and biomedical research.
  4. Biobank Services: Stockholms medicinska biobank provides services to researchers, pharmaceutical companies, and biotech firms, generating revenue through sample storage and access fees.

Pricing tiers

ModelBillingPrice
Unit PricingPer visitStandard patient visit fees

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Karolinska Universitetssjukhuset product offering

Product offering

Core offering

Karolinska Universitetssjukhuset is a public university hospital providing specialized and highly specialized healthcare to patients across Stockholm and Sweden. It operates two main campuses (Huddinge and Solna), runs over 1,000 clinical studies, and integrates clinical care with research, education and innovation in collaboration with Karolinska Institutet. Offerings include emergency and inpatient care, outpatient clinics, pediatric services (Astrid Lindgrens barnsjukhus), national highly specialized care assignments, digital patient services, a regional biobank, and clinical trial support.

Product overview

Karolinska Universitetssjukhuset operates as a university hospital with a portfolio of specialized healthcare services and digital platforms. Key offerings include Astrid Lindgrens barnsjukhus (children's hospital), digital patient services (Alltid Öppet, 1177 e-tjänster), Karolinska Hälsodata for health data extraction, Precisionsmedicinskt centrum Karolinska (PMCK) for precision medicine, Translational Research Center TRACK for clinical research, Karolinska Trial Alliance (KTA) for clinical trial services, and Stockholms medicinska biobank for sample storage. The hospital also offers Stepstones transition program for adolescent patients moving to adult care.

Differentiator

Problem solved

Functional benefit

Brands

  • Astrid Lindgrens barnsjukhus: A specialized pediatric hospital within Karolinska Universitetssjukhuset, providing specialized and highly specialized care for children from across Sweden. Handles approximately 180,000 patient visits per year including 55,000 acute visits.

Products and services

  • Astrid Lindgrens barnsjukhus (Astrid Lindgren Children's Hospital)
  • Alltid Öppet
  • 1177 e-tjänster
  • Karolinska Hälsodata
  • Precisionsmedicinskt centrum Karolinska (PMCK)
  • Translational Research Center Karolinska University Hospital (TRACK)
  • Karolinska Trial Alliance (KTA)
  • Stockholms medicinska biobank (Stockholm Medical Biobank)
  • Nationell högspecialiserad vård (National Highly Specialized Care)
  • Barnahus Stockholm

Quantifiable outcome

  • 4th best hospital in the world, best in Europe (2026 Newsweek ranking)
  • +4 more outcomes

Companies that use Karolinska Universitetssjukhuset

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Karolinska Universitetssjukhuset technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature6 records

Karolinska Universitetssjukhuset partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core, minor and major.

  • AstraZenecacoreStrategic or Co-development Partner · 18 June 2026Collaboration to strengthen precision medicine development in Sweden and improve conditions for patients. Partnership focuses on research collaboration and implementation of precision medicine approaches.
  • Okhmatdyt Children's Hospital (Ukraine)minorStrategic or Co-development Partner · 9 December 2025Fellowship program where Ukrainian healthcare professionals from Okhmatdyt in Kiev visit Astrid Lindgrens barnsjukhus for training and exchange. Ongoing collaboration supporting Ukraine's largest children's hospital.
  • Barnahus Stockholm Partners (Police, Prosecutor, Social Services, BUP)majorStrategic or Co-development Partner · 10 December 2024Multi-agency collaboration at Barnahus Stockholm (child protection center) bringing together police, prosecutor, social services, and child psychiatry under one roof. Largest Barnahus in Europe.
  • Île-de-France (Paris Region)minorStrategic or Co-development Partner · 28 June 2022Cooperation agreement signed between Region Stockholm and Île-de-France covering innovation, digital transformation, and sustainable future. Includes collaboration on AR in spine surgery and biotech.
  • MedTechLabsmajorStrategic or Co-development Partner · 28 June 2022Joint venture developing silicon-based computed tomography technology with potential for significant patient benefits if transitioned to clinical use. Regional partnership between academia, industry, and clinical care.
  • Oslo University Hospital / UllevålminorStrategic or Co-development Partner · 28 June 202220-year international collaboration on pediatric hospital care with exchange visits and experience sharing. Regular study visits between the institutions.
  • KTH Royal Institute of TechnologymajorTechnology or Integration · 7 June 2022Collaboration on AI development for breast cancer detection. AI program developed jointly with KTH to help radiologists identify patients who would benefit most from supplementary MRI examinations.
  • Karolinska InstitutetcoreStrategic or Co-development Partner · 29 April 2022Strategic partnership between Karolinska Universitetssjukhuset and Karolinska Institutet for medical research, education, and innovation. Includes joint biobank collaboration, Precisionsmedicinskt centrum Karolinska (PMCK), and Translational Research Center (TRACK). The partnership integrates healthcare, research, and education with shared facilities including BioClinicum.
  • Region StockholmcoreStrategic or Co-development Partner · 29 April 2022Karolinska Universitetssjukhuset operates as Region Stockholm's university hospital, providing specialized and highly specialized healthcare. Partnership includes Life Science strategy development and Stockholm Medical Biobank operations.
  • Stockholms medicinska biobank (SMB)coreStrategic or Co-development Partner · 29 April 2022Regional biobank operated by Karolinska for Region Stockholm serving patients at Karolinska, Södersjukhuset, Danderyds sjukhus, and Gotland. Over 45 million samples collected.
  • Genomic Medicine Sweden (GMS)coreStrategic or Co-development Partner · 26 April 2022National force for precision medicine implementation enabling all Swedish patients access to genetic sequencing for diagnosis and personalized treatment. Led by Richard Rosenquist Brandell from Karolinska.
  • Translational Research Center Karolinska (TRACK)coreStrategic or Co-development Partner · 26 April 2022Research hotel in Huddinge facilitating collaboration between preclinical and clinical researchers. Includes Karolinska Center for Cell Therapy, Mutation Analysis Unit, and Preclinical Imaging Unit (PIF).
  • EIT Health ScandinaviamajorStrategic or Co-development Partner · 1 April 2022International research collaboration for precision prevention in rheumatology receiving 23 million SEK grant. Partners include KI, Elsa Science, ThermoFisher Scientific, Friedrich Alexander University (Germany), and Leiden University Medical Center (Netherlands).
  • Karolinska Trial Alliance (KTA)coreStrategic or Co-development Partner · 1 September 2021Clinical trial support organization providing GCP training, clinical trial methodology courses, and research nurse education. Offers courses in Good Clinical Practice and clinical trial management.

Scale indicators9 records

Recent moves6 records

Expansion highlights6 records

Karolinska Universitetssjukhuset competitors and assessment

Company assessment

Direct peers

  • Sahlgrenska University Hospital: Sweden's second-largest university hospital in Gothenburg operated by Västra Götalandsregionen. Direct Nordic peer offering the same specialized and nationell högspecialiserad vård designations, similar clinical research scale, and competing for talent, research funding, and complex referrals from western Sweden.
  • Skåne University Hospital (SUS): University hospital in Lund/Malmö operated by Region Skåne, affiliated with Lund University. Comparable as a Swedish academic medical center providing tertiary and quaternary care, conducting similar clinical research, and competing for nationell högspecialiserad vård mandates.
  • Uppsala University Hospital (Akademiska sjukhuset): University hospital in Region Uppsala affiliated with Uppsala University. Direct peer providing specialized care and clinical research; recently joined Karolinska's AstraZeneca precision medicine collaboration, underscoring strategic overlap rather than pure competition.
  • Oslo University Hospital (Rikshospitalet): Norway's largest university hospital and Karolinska's 20-year pediatric collaboration partner. Comparable Nordic academic medical center providing national highly specialized care and competing for European Reference Network leadership and cross-border clinical research visibility.

Broad incumbents

  • Rigshospitalet (Copenhagen University Hospital): Denmark's flagship university hospital providing highly specialized national care. Comparable Nordic academic medical center, often larger in specific specialty areas, and competing with Karolinska for European Reference Network status and global patient referrals.
  • Helsinki University Hospital (HUS): Finland's largest hospital district and academic medical center. Comparable as a Nordic specialty hospital provider with active research portfolio and cross-border partnerships, serving as a peer for both patient referrals and clinical research collaborations.
  • Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals, jointly operated by Freie Universität Berlin and Humboldt-Universität. Comparable to Karolinska as a major European academic medical center with extensive research portfolio, large biobank infrastructure, and membership in multiple European Reference Networks.

Others

  • Karolinska Institutet: Sweden's premier medical university and Karolinska's primary academic partner. While a research and education institution rather than a healthcare provider, it is the closest comparable organization due to shared brand, joint biobank infrastructure (TRACK, PMCK), and overlapping talent pipeline that drives Karolinska's research output.

Regional players

  • University Hospital Zurich (USZ): Switzerland's largest university hospital providing highly specialized care and clinical research. Comparable European academic medical center that does not directly compete in the Nordics but competes for European Reference Network leadership and global reputation rankings.
  • Erasmus MC: University medical center in Rotterdam combining hospital care, research, and education. Comparable European academic medical center with strong AI and digital health capabilities, competing with Karolinska for European Reference Network participation and clinical research visibility.

Market position

Strengths4 records

Weaknesses3 records

Competitive moat6 records

Key risks4 records

Key highlights7 records

Customer concentration

Karolinska Universitetssjukhuset social profiles

Digital presence

Karolinska Universitetssjukhuset compliance and trust

Trust signal

Compliance1 record

Karolinska Universitetssjukhuset financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Karolinska Universitetssjukhuset leadership team

Management profile

Number of profiles

Profiles12 records

Karolinska Universitetssjukhuset subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Karolinska Universitetssjukhuset funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Karolinska Universitetssjukhuset M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Karolinska Universitetssjukhuset

What does Karolinska Universitetssjukhuset do?

Karolinska Universitetssjukhuset is a public university hospital providing specialized and highly specialized healthcare to patients across Stockholm and Sweden. It operates two main campuses (Huddinge and Solna), runs over 1,000 clinical studies, and integrates clinical care with research, education and innovation in collaboration with Karolinska Institutet. Offerings include emergency and inpatient care, outpatient clinics, pediatric services (Astrid Lindgrens barnsjukhus), national highly specialized care assignments, digital patient services, a regional biobank, and clinical trial support.

Is Karolinska Universitetssjukhuset a public or private company?

Karolinska Universitetssjukhuset is a public company. It is classified as state government owned and is currently operating.

When was Karolinska Universitetssjukhuset founded?

Karolinska Universitetssjukhuset was founded in 1940. It employs 5,001 to 10,000 people.

Where is Karolinska Universitetssjukhuset based?

Karolinska Universitetssjukhuset is headquartered in Huddinge, Sweden, in the Europe region.

How does Karolinska Universitetssjukhuset make money?

Four revenue lines are on record. Public Healthcare Funding is the primary driver. The others are patient Fees, research Grants and Funding and biobank Services.

Who are Karolinska Universitetssjukhuset's main competitors?

Direct peers on record are Sahlgrenska University Hospital, Skåne University Hospital (SUS), Uppsala University Hospital (Akademiska sjukhuset) and Oslo University Hospital (Rikshospitalet). Broad incumbents are Rigshospitalet (Copenhagen University Hospital), Helsinki University Hospital (HUS) and Charité – Universitätsmedizin Berlin. Karolinska Institutet is listed as an others. Regional players are University Hospital Zurich (USZ) and Erasmus MC.

Does Karolinska Universitetssjukhuset have an API?

No public API is recorded for Karolinska Universitetssjukhuset.

What industry is Karolinska Universitetssjukhuset in?

Karolinska Universitetssjukhuset's product category is University Hospital Services. Its primary akta.pro industry code is HLAFAHAC, Oncology & Cancer Specialty Hospitals, with a secondary code of HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs). Its NAICS code is 62211 and its SIC code is 8060.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Mirage NewsImportant Milestone For ALS Research And CareTofersen (Qalsody) was approved for patients with SOD1-ALS at Karolinska University Hospital, a breakthrough for a genetically defined ALS form. The approval took effect in June 2026, and researchers at Karolinska Institutet see it as a first step toward more personalized treatments.Mirage NewsSelenite Treatment Clears Lung Cancer TumorA patient with advanced, treatment-resistant lung cancer became tumor-free after receiving the selenium compound selenite, remaining in remission for ten years according to a case report from Karolinska University Hospital and Karolinska Institutet. Researchers observed a sharp decrease in the tumor marker sPD-L1, suggesting the treatment activated the immune system against the cancer. The study's authors are now planning larger confirmatory studies to investigate selenite as a potential global cancer treatment option.Mirage NewsGrant To Improve Dementia Risk AssessmentKarolinska Institutet researcher Ingrid Ekström has been awarded a grant of approximately USD 189,000 to investigate whether smell tests can improve early dementia risk assessment for individuals with subjective cognitive decline. The three-year project will combine olfactory testing with established biological markers using data from Swedish population studies and Karolinska University Hospital.Mirage NewsImproving Diagnosis Of Primary AldosteronismKarolinska University Hospital has implemented a new diagnostic method, the B2 ratio, for identifying primary aldosteronism based on research by Christofer Juhlin's group. This technique uses antibody staining against the CYP11B2 enzyme to distinguish between aldosterone-producing nodules, allowing for more accurate disease classification and prediction of surgical outcomes. The transition from research to routine clinical care aims to standardize diagnosis and improve patient treatment for this common cause of high blood pressure.Dagens industriEtt gyllene tillfälle att leda Europas hälsodatarevolutionThis opinion piece by hospital directors Christophe Pedroletti (Karolinska Universitetssjukhuset) and Marianne van Rooijen (Akademiska sjukhuset) argues that Sweden should position itself as a leading node in Europe's health data ecosystem by leveraging the comprehensive health data generated in Swedish healthcare.news.cision.comDexTech Medical's Myeloma Study, Dose Group 2, DMC Gives OK for Dose Group 3Swedish biotech company DexTech Medical announced that the Independent Data Monitoring Committee has approved progression to dose group 3 (9mg/kg) in their Phase I/II myeloma study, with dose group 2 (6mg/kg) now fully recruited. Two patients in dose group 2 experienced progressive disease after treatment completion, while two additional patients are expected to finish by early December; no ODX-related serious side effects have been reported. The study is being conducted at Karolinska University Hospital Huddinge and Uddevalla Hospital, with biomarker analysis at Karolinska University Hospital Solna.PR NewswireCVCO Therapeutics and Karolinska University Hospital Announce Collaboration to Advance Understanding of Microvascular Dysfunction Using Magnetic Resonance Perfusion ImagingCVCO Therapeutics and Karolinska University Hospital have executed a research agreement to conduct a Phase 2 clinical study evaluating a once-daily oral soluble guanylyl cyclase stimulator in patients with type 2 diabetes and established microvascular complications. The study will use magnetic resonance imaging perfusion to assess whether the treatment improves myocardial microvascular blood flow and protects cardiac function during ischemia-reperfusion. This collaboration targets a significant unmet need, as patients with type 2 diabetes face markedly elevated cardiovascular risk with currently limited therapeutic options addressing underlying microvascular dysfunction.WallenbergRevolutionary X-ray technology reaching clinicsHans Hertz from KTH Royal Institute of Technology is advancing liquid-metal-jet X-ray technology to enable real-time tumor analysis during surgery. The technology, developed in collaboration with Karolinska University Hospital, aims to provide sharper images and faster diagnostics compared to traditional methods. A spinoff company, Excillum, was previously founded based on this underlying liquid-metal-jet technology.PR NewswireOncorena's first patient treated with ONC175 (orellanine) in clinical phase I/II trial in patients with metastatic renal cancer and dialysis at Karolinska University Hospital in Stockholm, SwedenOncorena AB announced that the first patient has been treated in its Phase I/II clinical trial (Oncorella-1) of ONC175 (orellanine) for metastatic renal cancer in dialysis-dependent patients, with the treatment administered on August 8, 2023 at Karolinska University Hospital in Stockholm, Sweden. The trial will enroll up to 40 patients and is evaluating safety, tolerability, pharmacokinetics, and anti-tumor effects of the drug candidate. The company noted this milestone as significant given the unmet medical need for effective therapies in this patient population.PR NewswireOncorena's first patient treated with ONC175 (orellanine) in clinical phase I/II trial in patients with metastatic renal cancer and dialysis at Karolinska University Hospital in Stockholm, SwedenOncorena AB announced the first patient was treated with ONC175 (orellanine) in its Phase I/II clinical trial Oncorella-1 on August 8, 2023, at Karolinska University Hospital in Stockholm, Sweden. The trial enrolls patients with metastatic renal cancer who are dialysis-dependent and will assess safety, tolerability, pharmacokinetics, and anti-tumor effects in up to 40 patients. ONC175 is a first-in-class organ-targeted chemotherapy candidate with a unique mode of action developed specifically for this patient population that currently lacks curative treatment options.